These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31121093)

  • 1. Single Molecule Identification and Quantification of Glycosaminoglycans Using Solid-State Nanopores.
    Im J; Lindsay S; Wang X; Zhang P
    ACS Nano; 2019 Jun; 13(6):6308-6318. PubMed ID: 31121093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive structural assignment of glycosaminoglycan oligo- and polysaccharides by protein nanopore.
    Bayat P; Rambaud C; Priem B; Bourderioux M; Bilong M; Poyer S; Pastoriza-Gallego M; Oukhaled A; Mathé J; Daniel R
    Nat Commun; 2022 Aug; 13(1):5113. PubMed ID: 36042212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveying silicon nitride nanopores for glycomics and heparin quality assurance.
    Karawdeniya BI; Bandara YMNDY; Nichols JW; Chevalier RB; Dwyer JR
    Nat Commun; 2018 Aug; 9(1):3278. PubMed ID: 30115917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single conical track-etched nanopore for a free-label detection of OSCS contaminants in heparin.
    Ma T; Balanzat E; Janot JM; Balme S
    Biosens Bioelectron; 2019 Jul; 137():207-212. PubMed ID: 31100600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic heparan sulfate standards and machine learning facilitate the development of solid-state nanopore analysis.
    Xia K; Hagan JT; Fu L; Sheetz BS; Bhattacharya S; Zhang F; Dwyer JR; Linhardt RJ
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33688052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application.
    Hu P; Fang L; Chess EK
    Anal Chem; 2009 Mar; 81(6):2332-43. PubMed ID: 19228018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of Oversulphated Chondroitin Sulphate and Dermatan Sulphate in unfractionated heparin by (1)H-NMR - Collaborative study for quantification and analytical determination of LoD.
    McEwen I; Mulloy B; Hellwig E; Kozerski L; Beyer T; Holzgrabe U; Wanko R; Spieser JM; Rodomonte A
    Pharmeuropa Bio; 2008 Dec; 2008(1):31-9. PubMed ID: 19220979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.
    Zang Q; Keire DA; Buhse LF; Wood RD; Mital DP; Haque S; Srinivasan S; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    Anal Bioanal Chem; 2011 Aug; 401(3):939-55. PubMed ID: 21678118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive inhibition of heparinase by persulfonated glycosaminoglycans: a tool to detect heparin contamination.
    Aich U; Shriver Z; Tharakaraman K; Raman R; Sasisekharan R
    Anal Chem; 2011 Oct; 83(20):7815-22. PubMed ID: 21863856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive detection of oversulfated chondroitin sulfate in heparin sodium or crude heparin with a colorimetric microplate based assay.
    Sommers CD; Mans DJ; Mecker LC; Keire DA
    Anal Chem; 2011 May; 83(9):3422-30. PubMed ID: 21449571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophoresis for the analysis of heparin purity and quality.
    Volpi N; Maccari F; Suwan J; Linhardt RJ
    Electrophoresis; 2012 Jun; 33(11):1531-7. PubMed ID: 22736353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A versatile salt-based method to immobilize glycosaminoglycans and create growth factor gradients.
    Hof DJ; Versteeg EMM; van de Lest CHA; Daamen WF; van Kuppevelt TH
    Glycoconj J; 2019 Jun; 36(3):227-236. PubMed ID: 31055697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies.
    Coltrini D; Rusnati M; Zoppetti G; Oreste P; Isacchi A; Caccia P; Bergonzoni L; Presta M
    Eur J Biochem; 1993 May; 214(1):51-8. PubMed ID: 8508806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of an ion-exchange chromatography method for heparin and its impurities in heparin products.
    Thiangthum S; Vander Heyden Y; Buchberger W; Viaene J; Prutthiwanasan B; Suntornsuk L
    J Sep Sci; 2014 Nov; 37(22):3195-204. PubMed ID: 25146711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of possible economically motivated adulterants in heparin sodium and low molecular weight heparins with a colorimetric microplate based assay.
    Sommers CD; Keire DA
    Anal Chem; 2011 Sep; 83(18):7102-8. PubMed ID: 21819047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Software tool for the structural determination of glycosaminoglycans by mass spectrometry.
    Tissot B; Ceroni A; Powell AK; Morris HR; Yates EA; Turnbull JE; Gallagher JT; Dell A; Haslam SM
    Anal Chem; 2008 Dec; 80(23):9204-12. PubMed ID: 19551986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Beacon-Based Fluorescent Assay for Specific Detection of Oversulfated Chondroitin Sulfate Contaminants in Heparin without Enzyme Treatment.
    Lee CY; Tseng WL
    Anal Chem; 2015; 87(10):5031-5. PubMed ID: 25927411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of galactosamine impurities in heparin sodium using fluorescent labeling and conventional high-performance liquid chromatography.
    Itoh S; Hiruta Y; Hashii N; Fujita N; Natsuga T; Hattori T; Bando A; Sekimoto Y; Miyata K; Namekawa H; Mabuchi K; Sakai T; Shimahashi H; Kawai K; Yoden H; Koyama S; Herr SO; Natsuka S; Yamaguchi T; Kawasaki N
    Biologicals; 2013 Nov; 41(6):355-63. PubMed ID: 23827519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of a single enzyme molecule based on a solid-state nanopore sensor.
    Tan S; Gu D; Liu H; Liu Q
    Nanotechnology; 2016 Apr; 27(15):155502. PubMed ID: 26937593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting glycosaminoglycan surface protein interactions and implications for studying axonal growth.
    Griffith AR; Rogers CJ; Miller GM; Abrol R; Hsieh-Wilson LC; Goddard WA
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13697-13702. PubMed ID: 29229841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.